Duquesne
DHR · Medicine & biotech

Danaher

Makes lab tools and tests used by scientists and drug makers.
New: first time
Duquesne bought Danaher for the first time between April and June: 50,300 shares, worth about $10 million. That’s already less than $1 of every $100 they have in stocks.
Mar 31
None
Jun 30
50,300

The numbers

Shares they own
50,300
Value on Jun 30, 2026
$9,581,000
about $10 million
Share of their money
0.2%
less than $1 of every $100 · 68th of 85
Price per share on Jun 30
$190.48
Kind
Shares
More about Danaher
The value uses the price on Jun 30, 2026. The fund may have paid a different price.
Not investment advice. Holdings come from public SEC reports and the funds’ own letters, and can be up to 4½ months old. How this works